Capricor Therapeutics
CAPR
#7975
Rank
A$0.43 B
Marketcap
A$9.57
Share price
-4.36%
Change (1 day)
-59.16%
Change (1 year)

Capricor Therapeutics (CAPR) - Total assets

Total assets on the balance sheet as of September 2025 : A$0.19 Billion

According to Capricor Therapeutics 's latest financial reports the company's total assets are A$0.19 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Capricor Therapeutics - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31A$0.27 B217.93%
2023-12-31A$86.2 M17.11%
2022-12-31A$73.61 M29.13%
2021-12-31A$57 M26.62%
2020-12-31A$45.02 M183.63%
2019-12-31A$15.87 M20.93%
2018-12-31A$13.12 M-37.03%
2017-12-31A$20.84 M-19.85%
2016-12-31A$26 M17.9%
2015-12-31A$22.05 M32.43%
2014-12-31A$16.65 M168.29%
2013-12-31A$6.2 M18.96%
2012-12-31A$5.21 M289.99%
2011-12-31A$1.33 M-62.92%
2010-12-31A$3.6 M-10.43%
2009-12-31A$4.02 M-55.83%
2008-12-31A$9.12 M-53.33%
2007-12-31A$19.54 M
2006-12-31N/A-100%
2005-12-31A$0 M-53.2%
2004-12-31A$0 M-43.47%
2003-12-31A$0 M3171.4%
2002-12-31A$0 M-90.68%
2001-12-31A$0 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Cytokinetics
CYTK
A$2.16 B 1,036.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
A$5.6 M-97.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$290.05 B 152,398.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
A$6.41 B 3,273.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
A$0.97 B 412.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
A$9.28 M-95.12%๐Ÿ‡บ๐Ÿ‡ธ USA